There will be more than a hint of change, a bit of uncertainty, plus signs of global solidarity, when the Personal Consumer Product Council opens its annual meeting on Feb. 27 at The Breakers in Palm Beach, Fla. Among the key questions are who will be the next commissioner of the U.S. Food and Drug Administration (Silicon Valley investor Jim O’Neill is a name that has surfaced in the press), the shift in regulatory battles from Washington, D.C., to the individual states and how to recapture the hard-won gains made earlier in negotiating multinational trade pacts, principally the 12-nation Trans Pacific Partnership that has been scrapped, and NAFTA that has been earmarked that for renegotiation. The new administration of President Trump figures strongly in most of these issues. He will not be in the meeting room — although his Mar-a-Lago weekend retreat is down the road from the hotel — but his influence is sure to be felt. A top-priority for Thia Breen, who is beginning her third and final year as PCPC chairman, is passage of the personal-care safety bill first proposed by Sen. Dianne Feinstein (D., Calif.) and Sen. Susan Collins (R., Maine) in 2015. While proposing to modernize oversight of
Follow WWD on Twitter or become a fan on Facebook.
Read More...
from WWDWWD http://ift.tt/2lD2JSh
via
IFTTT